tiprankstipranks
Trending News
More News >
U.s. Physical Therapy (USPH)
NYSE:USPH
US Market

US Physical Therapy (USPH) Ratios

Compare
99 Followers

US Physical Therapy Ratios

USPH's free cash flow for Q4 2024 was $0.18. For the 2024 fiscal year, USPH's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.18 2.28 1.30 1.14 0.94
Quick Ratio
1.18 2.28 1.33 1.14 0.94
Cash Ratio
0.36 1.50 0.37 0.34 0.35
Solvency Ratio
0.11 0.09 0.16 0.23 0.34
Operating Cash Flow Ratio
0.64 0.80 0.68 0.92 1.07
Short-Term Operating Cash Flow Coverage
6.81 10.66 1.41 2.44 3.09
Net Current Asset Value
$ -270.84M$ -111.63M$ -262.32M$ -201.82M$ -96.75M
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.26 0.34 0.30 0.19
Debt-to-Equity Ratio
0.60 0.54 0.94 0.75 0.40
Debt-to-Capital Ratio
0.38 0.35 0.48 0.43 0.29
Long-Term Debt-to-Capital Ratio
0.23 0.23 0.36 0.39 0.22
Financial Leverage Ratio
2.39 2.09 2.72 2.54 2.15
Debt Service Coverage Ratio
3.80 3.66 1.35 2.18 1.90
Interest Coverage Ratio
7.89 7.48 9.83 81.50 32.08
Debt to Market Cap
0.11 0.11 0.21 0.18 0.07
Interest Debt Per Share
20.13 18.88 23.19 17.37 8.77
Net Debt to EBITDA
2.92 1.42 3.47 2.27 1.01
Profitability Margins
Gross Profit Margin
22.11%18.52%20.25%23.67%22.33%
EBIT Margin
12.17%9.70%11.09%14.98%15.88%
EBITDA Margin
15.50%12.30%13.76%17.32%18.37%
Operating Profit Margin
11.28%11.50%10.27%15.51%12.39%
Pretax Profit Margin
10.74%8.16%10.05%14.79%15.49%
Net Profit Margin
4.72%2.43%7.85%11.70%12.41%
Continuous Operations Profit Margin
8.13%6.15%7.85%11.70%12.41%
Net Income Per EBT
43.95%29.72%78.11%79.14%80.12%
EBT Per EBIT
95.25%70.99%97.83%95.34%124.99%
Return on Assets (ROA)
2.27%1.47%5.06%7.73%8.83%
Return on Equity (ROE)
5.41%3.08%13.75%19.60%19.01%
Return on Capital Employed (ROCE)
6.01%7.77%7.35%11.53%10.46%
Return on Invested Capital (ROIC)
4.51%5.59%5.23%8.35%7.49%
Return on Tangible Assets
8.24%3.88%17.00%25.36%27.28%
Earnings Yield
1.98%1.11%4.13%4.70%3.40%
Efficiency Ratios
Receivables Turnover
6.54 11.66 10.65 10.70 10.09
Payables Turnover
73.56 126.43 67.82 58.39 246.08
Inventory Turnover
0.00 0.00 -154.35 377.84M 328.52M
Fixed Asset Turnover
3.38 4.67 4.33 4.15 4.10
Asset Turnover
0.48 0.61 0.64 0.66 0.71
Working Capital Turnover Ratio
7.35 7.71 29.53 169.85 44.60
Cash Conversion Cycle
50.82 28.41 26.52 27.87 34.68
Days of Sales Outstanding
55.78 31.30 34.27 34.12 36.16
Days of Inventory Outstanding
0.00 0.00 -2.36 <0.01 <0.01
Days of Payables Outstanding
4.96 2.89 5.38 6.25 1.48
Operating Cycle
55.78 31.30 31.90 34.12 36.16
Cash Flow Ratios
Operating Cash Flow Per Share
4.97 5.78 4.51 5.92 7.79
Free Cash Flow Per Share
4.36 5.12 3.87 5.29 7.20
CapEx Per Share
0.61 0.66 0.64 0.64 0.60
Free Cash Flow to Operating Cash Flow
0.88 0.89 0.86 0.89 0.92
Dividend Paid and CapEx Coverage Ratio
2.10 2.45 1.98 2.83 8.51
Capital Expenditure Coverage Ratio
8.16 8.82 7.10 9.32 13.09
Operating Cash Flow Coverage Ratio
0.25 0.32 0.20 0.34 0.90
Operating Cash Flow to Sales Ratio
0.13 0.14 0.11 0.15 0.24
Free Cash Flow Yield
4.92%5.50%4.78%5.53%5.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
50.50 90.06 24.24 21.28 29.40
Price-to-Sales (P/S) Ratio
2.38 2.18 1.90 2.49 3.65
Price-to-Book (P/B) Ratio
2.73 2.78 3.33 4.17 5.59
Price-to-Free Cash Flow (P/FCF) Ratio
20.32 18.18 20.92 18.07 16.71
Price-to-Operating Cash Flow Ratio
17.83 16.12 17.97 16.13 15.43
Price-to-Earnings Growth (PEG) Ratio
1.66 -1.46 -0.95 2.18 -3.30
Price-to-Fair Value
2.73 2.78 3.33 4.17 5.59
Enterprise Value Multiple
18.30 19.19 17.29 16.64 20.87
Enterprise Value
1.59B 1.43B 1.32B 1.43B 1.62B
EV to EBITDA
18.30 19.19 17.29 16.64 20.87
EV to Sales
2.84 2.36 2.38 2.88 3.83
EV to Free Cash Flow
24.18 19.64 26.17 20.92 17.56
EV to Operating Cash Flow
21.22 17.41 22.48 18.68 16.22
Tangible Book Value Per Share
-5.80 2.32 -9.11 -5.32 0.63
Shareholders’ Equity Per Share
32.46 33.56 24.32 22.92 21.52
Tax and Other Ratios
Effective Tax Rate
0.24 0.25 0.22 0.21 0.20
Revenue Per Share
37.21 42.63 42.60 38.38 32.95
Net Income Per Share
1.76 1.03 3.34 4.49 4.09
Tax Burden
0.44 0.30 0.78 0.79 0.80
Interest Burden
0.88 0.84 0.91 0.99 0.98
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.09 0.08 0.09 0.10
Stock-Based Compensation to Revenue
0.01 0.01 0.01 0.02 0.02
Income Quality
1.64 2.20 1.35 1.32 1.90
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis